Personalized Care for Prenatal Stress Reduction & Prevention of Preterm Birth (PTB) Disparities
NCT ID: NCT06915428
Last Updated: 2026-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
1228 participants
INTERVENTIONAL
2026-02-01
2029-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Does the PTBCARE+ patient support program lower patient-reported stress levels during pregnancy?
* Does the PTBCARE+ patient support program improve biologic measures of stress during pregnancy?
* Does the PTBCARE+ patient support program result in a higher chance of delivering a healthy baby at or close to full term?
Researchers will compare people who participate in the PTBCARE+ patient support program to those receive usual care to see if the PTBCARE+ patient support program lowers patient-reported stress, improves biologic measures of stress, and increases the chance of delivering a healthy baby at or close to full term.
Participants will be randomly assigned to receive the PTBCARE+ patient support program or usual prenatal care.
All participants will be asked to:
* complete 2 study visits during pregnancy - including completing electronic surveys, providing a blood and urine sample, measuring the heart rate variability by a clip or the ear or finger, and body composition evaluation using a simple scale-like device.
* complete one study visit postpartum that includes completing electronic surveys, and measuring heart rate variability. Blood and urine sample collection and body composition evaluation via InBody scale are optional at the postpartum visit.
People who are randomly assigned to receive the PTBCARE+ support program will receive several resources to help them during pregnancy. These things include items such as:
* a stress reduction toolkit;
* access to an online website that can also be downloaded as a smart phone app;
* the option to receive an electronic massage while in clinic, and more.
* additional support gifts provided at routine clinical appointments
People who are randomly assigned to receive usual prenatal care will not receive any additional support resources from the study during pregnancy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Provider RCT PROMOTE
NCT07126405
Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB
NCT03418012
Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children's Long-Term Outcome
NCT03418311
The Periviable Birth Plan
NCT03061864
Evaluation of a New Predictive Test of Preterm Birth in Case of Threatened Preterm Labor
NCT04374916
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The central hypothesis of this project is that enrollment in a personalized, comprehensive PTB support program (UNC PTBCARE+) is associated with reduced perceived stress, stress-related gene expression, allostatic load, and lower rates of PTB \<35 weeks. This hypothesis is supported by published and preliminary data as follows: First, UNC pregnant patients at high risk for PTB have high rates of stress and life stressors (e.g., financial insecurity, racism). Second, biologic stress markers including gene transcript levels differ by PTB status in mid-pregnancy blood. Third, specialty PTB care reduces stress in a NC cohort. Building upon prior work and that of others, this exciting proposal evaluates the efficacy of the novel UNC PTBCARE+ program.
The investigation focus on PTB \<35 weeks due to its relative frequency, higher association with neonatal morbidity and mortality as compared to later PTB, to include PTB in the 34th week of gestation (because the delivery gestational age considered 'standard of care' for delivery among individuals with stable but severe preeclampsia and preterm membrane rupture), and to align with multiple other published PTB RCTs. This study will recruit 1,350 pregnant patients between 8+0 and 19+6 weeks gestation with an elevated a priori risk of either medically-indicated preterm birth or spontaneous preterm birth. Subjects will be randomized 2:1 to receive UNC PTBCARE+ vs. usual care. Randomization will be stratified based on maternal race and ethnicity (individuals who identify only as White and non-Hispanic vs. individuals who identify as belonging to one or more other races and/or Hispanic ethnicity and (b) perceived stress scores (those with perceived stress scores ≥20 vs. those with lower perceived stress scores scores).
All participants, regardless of randomization assignment, will have 2 study visits during pregnancy.
* Visit 1 (V1) will occur at randomization, 8+0 - 19+6 weeks gestation.
* Visit 2 (V2) will occur in mid pregnancy, between 22+0 and 29+6 weeks gestation.
At both visits, patients will complete validated surveys evaluating a broad spectrum of stressors, discrimination, adverse childhood experiences, perceived social support, resiliency, medication barriers and adherence, care access and satisfaction,, intervention fidelity and sustainability, use of stress relief modalities, and have blood collected to measure biologic stress markers.
The UNC PTBCARE+ program is personalized. All patients randomized to UNC PTBCARE+ receive a stress reduction toolkit and will work with a PTB Care Coordinator who will provide support, facilitate clinician-prescribed medical care, and serve as a patient-provider liaison. Additional benefits / support items and support elements are provided to some participants on an "as needed" basis, per study protocol, and are not included in the initial registration to preserve scientific integrity and protect the rights of research participants. This study registration will be updated with complete intervention details after the study is fully enrolled and all participants have delivered.
Psychosocial and financial stressor screening results from V1 will determine UNC PTBCARE+ tier assignment. Thus, participants are randomized only after Visit 1 surveys are completed.
This solutions-oriented RCT of UNC PTBCARE+ vs. usual care provides an ideal forum to test the primary hypothesis and study stress-related PTB pathophysiology through the following Aims:
* Aim 1. Evaluate the effects of the UNC PTBCARE+ program on perceived stress and resilience in pregnant patients at high risk for PTB. Hypothesis: Patients randomized to UNC PTBCARE+ will have lower levels of perceived stress and higher levels of resilience at V2 vs. V1; those randomized to usual care will have no change.
* Aim 2. Quantify the extent to which the UNC PTBCARE+ program is associated with improved biologic stress measures during pregnancy. Hypothesis: Patients randomized to UNC PTBCARE+ will have reduced stress-related gene expression and allostatic load scores in maternal blood at V2 vs. V1 compared to those randomized to usual care who will have no change, increasing insight into PTB pathophysiology.
* Aim 3. Determine the effects of the UNC PTBCARE+ program on PTB \<35 weeks. Hypothesis: Patients randomized to UNC PTBCARE+ will have lower rates of early PTB compared to those randomized to usual care.
This study provides tangible, personalized solutions to the major public health problem of PTB and carries enormous potential to provide generalizable, low-risk strategies to reduce PTB and related disparities.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Personalized Toolkit Building a Comprehensive Approach to Resource (PTBCARE+) Support Program
The UNC Personalized Toolkit Building a Comprehensive Approach to Resource optimization and Empowerment in Pregnancy \& Beyond (PTBCARE+) program is a multifaceted, personalized support program designed to help pregnant people at high risk for preterm birth. It enhances the prenatal care experience by adding extensive support resources.
Care coordination
Research team members will serve as research assistants and will also function as perinatal care coordinators.
In the care coordination role, team members will provide emotional support, liaise with clinical staff, and execute regularly scheduled check-ins with each study participant. Team members also assist with helping participants with logistics, obtaining and remembering to take prescribed medications, and other similar related activities. Participants receive access to contact the research assistant / care coordinator by text, email, phone, or through the electronic medical record participant portal.
\- Per protocol, the research staff will meet in person with participants at least twice (visit 1, visit 2) during pregnancy and once postpartum (0-10 weeks after delivery, for most participants).
Research staff may also meet in person with participants prior to visit 1 for recruitment/enrollment purposes.
Electronic massage
Participant is given the option to receive a 15-minute electronic massage / relaxation session in clinic via (a) a specialized massage chair or (b) a massage pad that is placed on top of a standard recliner chair.
* the electronic massages provide gentle massages and are safe for most people to use throughout pregnancy.
* participants are always be in control of the massage experience and will be given instructions on how to stop the massage at any time.
* participants are advised to consult the primary obstetric provider before using the massage chair regarding any specific concerns or questions
* during the session, participants may view relaxation videos (from free, publicly available sites online).
* participants may choose to sign up for massage(s) at any obstetric visit in the clinic between visit 1 and delivery.
support gift #1
* Small gift packet with encouraging items (example of items = coloring kit, tea lights, stickers, bookmarks, keychain fidget toy, printed support index cards, and other similar items).
* Given between 14+0 and 23+6 weeks gestation at time of routine prenatal appointment
Support gift #2
* Small gift packet with encouraging items (example of items = coloring kit, tea lights, stickers, bookmarks, keychain fidget toy, printed support index cards, and other similar items).
* Given between 18+0 and 27+6 weeks gestation at time of routine prenatal appointment
Support gift #3
* Small gift packet with encouraging items (example of items = coloring kit, tea lights, stickers, bookmarks, keychain fidget toy, printed support index cards, and other similar items).
* Given between 22+0 and 29+6 weeks gestation at time of routine prenatal appointment
Support gift #4
* Small gift packet with encouraging items (example of items = coloring kit, tea lights, stickers, bookmarks, keychain fidget toy, printed support index cards, and other similar items).
* Given between 26+0 and 33+6 weeks gestation at time of routine prenatal appointment
Additional PTBCARE+ support
Additional benefits / support items and support elements are provided to some participants on an "as needed" basis, per study protocol.
* Information / details intentionally withheld and not made public in order to preserve the scientific validity of the study and protect the rights of the research participants
* participant eligibility for additional resources as a part of the PTBCARE+ program will be determined by the research staff on the day of Visit 1 after initial set of surveys are completed, and is per protocol
Stress reduction toolkit - Visit 1 (V1)
In person check-in with research team member re: participant's needs; research team member provides support.
Physical items that are included as part of this visit include:
Tote bag with the following stress reduction items or similar:
* eye mask
* set of pocket index cards, printed back and front, on a variety of topics that influence pregnancy health, ranging from physical to emotional/mental
* water bottles
* small notebook
* pill minder case
* magnet and business card for Health Resources and Services Administration (HRSA) national maternal mental health hotline
* log in codes for electronic resources
* initial handouts with self care plan, introduction to stress reduction toolkit, etc.
PTBCARE+ mobile application (app) and website
Comprehensive, study-specific app that is available as a website or as a downloadable application that includes personalized, interactive modules and resources
* no study related materials are available without a password
* goal is to collate reputable sources of information to make investigating things online easier
* includes optional educational modules for participants
* also includes option of entering stress, well-being, blood sugar, blood pressure, etc. values with option to easily download recorded values for patient's clinical team
* available online (computer/laptop), tablet, or smart phone. can be downloaded as a progressive web application (PWA) to a local device and used without internet access
* Electronic access to the PTBCARE+ website will continue through 10 weeks postpartum unless the participant delivered \<16+0 weeks gestation in which case access will continue through 4 weeks postpartum
Sleep, meditation, and Wellness app
* complimentary one-year subscription to Aura - an 'all-in-one' wellbeing app that contains an enormous library of meditations, stories, breath work, work wellness, music, sounds, and more!
* Participants can access this app as needed throughout pregnancy and beyond, for up to one year after the date of enrollment
Emergency low blood sugar kit
Pouch contains:
* printed index card with information about signs and symptoms of low blood sugar
* printed index card with information about what to do if blood sugar is low
* 2-3 non-perishable, individually wrapped over the counter candy / glucose-raising options; use for low blood sugar treatment is described on the card
Only participants who have a diagnosis of diabetes mellitus or glucose intolerance AND have been prescribed an oral medication for blood sugar control or have been prescribed insulin are eligible to receive this.
Each participant can receive a maximum of two kits during pregnancy; first at enrollment, and the other at visit 2 or until delivery
Low dose aspirin (LDA)
* Bottle of 90-100 pills (depending on manufacturer)
* Provided at Visit 1 (after randomization)
* Patients who received a bottle of low-dose aspirin at Visit 1 are offered a 2nd bottle at Visit 2.
All patients whose provider recommends or prescribes either 81mg or 162mg of LDA during pregnancy are offered LDA as described herein. LDA must be on the patient's med list or specific notes from the patient's prenatal provider must explicitly note that it is recommended the patient take LDA in pregnancy for it to be offered. Individuals who are receiving LDA due to participation in another study are not eligible to receive LDA from PTBCARE+
Please note that this is listed as a "behavioral" intervention rather than "drug" intervention because the rational behind providing this over the counter medication is to help make the participant's life easier, and the focus is not on the efficacy of LDA. As such, it is being provided as a behavioral intervention.
Visit #2 Stress Reduction Toolkit
In person check-in with research team member re: participant's needs; research team member provides support.
Physical items that are included as part of this visit include the following stress reduction items or similar:
1. Frame + ultrasound photo + certificate of achievement!
* Picture from anatomy ultrasound (or other subsequent ultrasound) is downloaded, printed, and placed in frame.
* Certificate of achievement is printed and placed on other side of frame with ultrasound photo
2. other small items including stickers, printed index cards with supportive messaging, etc.
Usual Prenatal Care
Participants who are randomized to receive usual care will not receive the PTBCARE+ program. Research team members may contact participants only to remind them of study activities, and will conduct standard in-person follow-up visits per study protocol, but will not provide any additional information or support. Usual care participants will receive standardized resources offered to all prenatal patients in clinic per clinical provider discretion.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Care coordination
Research team members will serve as research assistants and will also function as perinatal care coordinators.
In the care coordination role, team members will provide emotional support, liaise with clinical staff, and execute regularly scheduled check-ins with each study participant. Team members also assist with helping participants with logistics, obtaining and remembering to take prescribed medications, and other similar related activities. Participants receive access to contact the research assistant / care coordinator by text, email, phone, or through the electronic medical record participant portal.
\- Per protocol, the research staff will meet in person with participants at least twice (visit 1, visit 2) during pregnancy and once postpartum (0-10 weeks after delivery, for most participants).
Research staff may also meet in person with participants prior to visit 1 for recruitment/enrollment purposes.
Electronic massage
Participant is given the option to receive a 15-minute electronic massage / relaxation session in clinic via (a) a specialized massage chair or (b) a massage pad that is placed on top of a standard recliner chair.
* the electronic massages provide gentle massages and are safe for most people to use throughout pregnancy.
* participants are always be in control of the massage experience and will be given instructions on how to stop the massage at any time.
* participants are advised to consult the primary obstetric provider before using the massage chair regarding any specific concerns or questions
* during the session, participants may view relaxation videos (from free, publicly available sites online).
* participants may choose to sign up for massage(s) at any obstetric visit in the clinic between visit 1 and delivery.
support gift #1
* Small gift packet with encouraging items (example of items = coloring kit, tea lights, stickers, bookmarks, keychain fidget toy, printed support index cards, and other similar items).
* Given between 14+0 and 23+6 weeks gestation at time of routine prenatal appointment
Support gift #2
* Small gift packet with encouraging items (example of items = coloring kit, tea lights, stickers, bookmarks, keychain fidget toy, printed support index cards, and other similar items).
* Given between 18+0 and 27+6 weeks gestation at time of routine prenatal appointment
Support gift #3
* Small gift packet with encouraging items (example of items = coloring kit, tea lights, stickers, bookmarks, keychain fidget toy, printed support index cards, and other similar items).
* Given between 22+0 and 29+6 weeks gestation at time of routine prenatal appointment
Support gift #4
* Small gift packet with encouraging items (example of items = coloring kit, tea lights, stickers, bookmarks, keychain fidget toy, printed support index cards, and other similar items).
* Given between 26+0 and 33+6 weeks gestation at time of routine prenatal appointment
Additional PTBCARE+ support
Additional benefits / support items and support elements are provided to some participants on an "as needed" basis, per study protocol.
* Information / details intentionally withheld and not made public in order to preserve the scientific validity of the study and protect the rights of the research participants
* participant eligibility for additional resources as a part of the PTBCARE+ program will be determined by the research staff on the day of Visit 1 after initial set of surveys are completed, and is per protocol
Stress reduction toolkit - Visit 1 (V1)
In person check-in with research team member re: participant's needs; research team member provides support.
Physical items that are included as part of this visit include:
Tote bag with the following stress reduction items or similar:
* eye mask
* set of pocket index cards, printed back and front, on a variety of topics that influence pregnancy health, ranging from physical to emotional/mental
* water bottles
* small notebook
* pill minder case
* magnet and business card for Health Resources and Services Administration (HRSA) national maternal mental health hotline
* log in codes for electronic resources
* initial handouts with self care plan, introduction to stress reduction toolkit, etc.
PTBCARE+ mobile application (app) and website
Comprehensive, study-specific app that is available as a website or as a downloadable application that includes personalized, interactive modules and resources
* no study related materials are available without a password
* goal is to collate reputable sources of information to make investigating things online easier
* includes optional educational modules for participants
* also includes option of entering stress, well-being, blood sugar, blood pressure, etc. values with option to easily download recorded values for patient's clinical team
* available online (computer/laptop), tablet, or smart phone. can be downloaded as a progressive web application (PWA) to a local device and used without internet access
* Electronic access to the PTBCARE+ website will continue through 10 weeks postpartum unless the participant delivered \<16+0 weeks gestation in which case access will continue through 4 weeks postpartum
Sleep, meditation, and Wellness app
* complimentary one-year subscription to Aura - an 'all-in-one' wellbeing app that contains an enormous library of meditations, stories, breath work, work wellness, music, sounds, and more!
* Participants can access this app as needed throughout pregnancy and beyond, for up to one year after the date of enrollment
Emergency low blood sugar kit
Pouch contains:
* printed index card with information about signs and symptoms of low blood sugar
* printed index card with information about what to do if blood sugar is low
* 2-3 non-perishable, individually wrapped over the counter candy / glucose-raising options; use for low blood sugar treatment is described on the card
Only participants who have a diagnosis of diabetes mellitus or glucose intolerance AND have been prescribed an oral medication for blood sugar control or have been prescribed insulin are eligible to receive this.
Each participant can receive a maximum of two kits during pregnancy; first at enrollment, and the other at visit 2 or until delivery
Low dose aspirin (LDA)
* Bottle of 90-100 pills (depending on manufacturer)
* Provided at Visit 1 (after randomization)
* Patients who received a bottle of low-dose aspirin at Visit 1 are offered a 2nd bottle at Visit 2.
All patients whose provider recommends or prescribes either 81mg or 162mg of LDA during pregnancy are offered LDA as described herein. LDA must be on the patient's med list or specific notes from the patient's prenatal provider must explicitly note that it is recommended the patient take LDA in pregnancy for it to be offered. Individuals who are receiving LDA due to participation in another study are not eligible to receive LDA from PTBCARE+
Please note that this is listed as a "behavioral" intervention rather than "drug" intervention because the rational behind providing this over the counter medication is to help make the participant's life easier, and the focus is not on the efficacy of LDA. As such, it is being provided as a behavioral intervention.
Visit #2 Stress Reduction Toolkit
In person check-in with research team member re: participant's needs; research team member provides support.
Physical items that are included as part of this visit include the following stress reduction items or similar:
1. Frame + ultrasound photo + certificate of achievement!
* Picture from anatomy ultrasound (or other subsequent ultrasound) is downloaded, printed, and placed in frame.
* Certificate of achievement is printed and placed on other side of frame with ultrasound photo
2. other small items including stickers, printed index cards with supportive messaging, etc.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Gestational age at first ultrasound by last menstrual period (LMP) / Ultrasound method / Measurement agreement with LMP required • Up to 8 weeks 6 days / crown rump length / ± 5 days
* 9 weeks 0 days to 13 weeks 6 days / crown rump length / ± 7 days
* 14 weeks 0 days to 15 weeks 6 days / standard fetal biometry / ± 7 days
* 16 weeks 0 days to 19 weeks 6 days / standard fetal biometry / ± 10 days
* Gestational dating / fetal viability must be confirmed by ultrasound prior to enrollment / randomization.
* Ultrasound report must include documentation of normal fetal heart rate of ≥ 120 beats per minute, or subsequent medical record documentation of auscultation of fetal heart rate ≥ 120 beats per minute.
* Viability must be confirmed / re-confirmed within 7 days of randomization.
If initial consent occurs early in pregnancy and V1/randomization occur later, viability must be reconfirmed to ensure ongoing eligibility prior to initiating V1 activities (including surveys) and proceeding with randomization.
2. No signs or symptoms of, or clinical diagnosis of, evolving miscarriage, active preterm labor, preterm prelabor rupture of membranes at the time of enrollment.
* Cervical dilation at the time of enrollment is an exclusion criterion. However, cervical evaluation and digital cervical exam is not required prior to enrollment.
(3a) High a priori risk for medically indicated preterm birth - must meet at least one of the following 3 criteria (maternal medical history, prior pregnancy history, or moderate risk factor history)
* miPTB criteria #1: Maternal Medical History - any one of the following:
o Known chronic hypertension requiring medications in the 3 months prior to conception or prior to 22 weeks gestation.
o At least 2 blood pressure readings 6 hours apart, \<20 weeks gestation, with systolic ≥ 130 mmHg or diastolic ≥ 80 mmHg \*regardless of need for medication or formal diagnosis of hypertension in chart\*
o Pre-gestational diabetes mellitus.
* Diabetes diagnosed \<20 weeks gestation.
* Maternal chronic or sub-acute renal disease, including chronic kidney failure, chronic renal insufficiency, glomerulonephritis, lupus nephritis, defined as any:
\*biopsy proven chronic renal disease history; and/or
\*serum creatinine ≥ 1.1 mg/dL at any time during pregnancy prior to enrollment, in the absence of other identifiable transient factors per clinician's assessment (e.g., extreme dehydration, cystitis, pyelonephritis); and/or
\*chronic proteinuria, defined as baseline urine protein:creatinine ratio ≥ 0.30 mg/dL or 24 hour total urine protein ≥ 300 mg in the absence of other identifiable transient factors per clinician's assessment (e.g., extreme dehydration, cystitis, pyelonephritis)
\*Systemic Lupus Erythematosus
* Antiphospholipid Antibody Syndrome
* miPTB criteria #2: Prior pregnancy history - any ONE of the following: o Previous pregnancy complicated by preeclampsia or hypertensive disorders of pregnancy at any gestational age, in a singleton gestation; the fetus must not have had major structural anomalies or aneuploidy.
o Previous history of stillbirth ≥ 16+0 weeks in a singleton gestation; the fetus must not have had major structural anomalies or aneuploidy. The stillbirth etiology must not have been attributed to physical trauma (e.g., domestic violence, motor vehicle accident) or illicit drug use (e.g., cocaine use leading to abruption and stillbirth).
* miPTB criteria #3: Any two or more of the following moderate risk factors: o Nulliparity, defined as no prior pregnancy to reach at least 20 weeks gestation note that this is the traditional / classic definition of 'nulliparous' and that there is overlap between nulliparity as defined this way and 'preterm birth' due to cervical insufficiency, which allows for deliveries in the 16-19 week gestational age range to be considered as 'preterm births'
o Obesity: current or pre-pregnancy body mass index ≥30 kg/m\^2
o Family history: first degree relative with a history of preeclampsia
o Advanced maternal age: maternal age ≥ 35 years at estimated date of confinement
o Prior adverse obstetric history - one or more of the following:
\- history of low birth weight or small for gestational age baby in a singleton gestation, defined as weight \<10% for gestational age and fetal sex; the fetus must not have had major structural anomalies or aneuploidy.
\- history of adverse pregnancy outcome in a singleton gestation; the fetus must not have had major structural anomalies or aneuploidy.
o Long interpregnancy interval: ≥ 10 year (3650 day) pregnancy interval, defined as the time (in days) between the date of delivery of the last pregnancy to reach ≥ 20 weeks gestation and the first day of the last menstrual period for the current pregnancy.
o Black or African-American race (as a proxy for underlying racism) - self-reported. Participants who self-identify as being of more than one racial group will be considered to be of Black race for the purposes of this criterion if one of the racial groups is Black or African-American.
* Low socioeconomic status, defined as one or more of the following: housing or food insecurity noted in chart within the last year, self-pay or Medicaid insurance, less than high school education
and/or
(3b) High a priori risk for spontaneous preterm birth - must meet at least one of the following 2 criteria (prior pregnancy history or current pregnancy course)
* sPTB criteria #1: Prior pregnancy history
* EITHER a history of a delivery of a singleton, non-anomalous baby between 16+0 and 34+6 weeks gestation or delivery of a twin, non-anomalous pregnancy between 160 /7and 276 /7 weeks gestation due to spontaneous preterm labor, preterm premature rupture of membranes, cervical insufficiency, or placental abruption - Chart documentation of prior preterm birth, the gestational age of the prior preterm birth (referred to as the 'qualifying delivery') should be determined. If the gestational age at delivery is obtained directly from the medical record and more than one gestational age appears, the greater of the two will be used assuming that neither is the 'source document' (i.e. an ultrasound report with a due date, a c-section report, a delivery note, etc).
Use the following table as a validation of the previous delivery. For example, if the infant was male and weighed more than 2763 grams (6 pounds, 1.5 ounces) then the patient would be ineligible based on history of a preterm birth criteria. This table should only be used to determine whether the qualifying delivery is most likely to be preterm less than 35 weeks gestation when the gestational age CANNOT be verified/calculated by review of the medical records or is not available in the medical records.
Gestational age 90th percentile - boys 90th percentile - girls 33 weeks \> 2488g 5 lbs 7.8 oz \> 2116g 4 lbs 10.6 oz 34 weeks \> 2763g 6 lbs 1.5 oz \> 2379g 5 lbs 3.9 oz 35 weeks \> 3084g 6 lbs 12.8 oz \> 2661g 5 lbs 13.9 oz
* Documented history of a prior pregnancy complicated by asymptomatic cervical shortening \<25mm between 16+0 and 23+6 weeks gestation or cervical dilation ≥ 0.5cm requiring cervical cerclage placement prior to 24+0 weeks gestation, even if delivery ultimately occurred ≥ 35 weeks gestation or at term.
• sPTB criteria #2: Current pregnancy course
* Asymptomatic cervical shortening \<25mm in the current pregnancy, diagnosed by transvaginal ultrasound that is performed ≥14+0 weeks gestation, per Registered Diagnostic Medical Sonographer(RDMS) certified Sonographer or physician with transvaginal ultrasound training program (or similar) qualifications
* Cervical cerclage in situ in the current pregnancy due to concern for risk of preterm birth, at the discretion of the primary obstetric provider
(4) Ability to provide written, informed consent in English or Spanish
(5) Planned prenatal care at the University of North Carolina at Chapel Hill obstetrics clinics and planned delivery at the University of North Carolina Women's Hospital (Chapel Hill, NC).
12. Known HIV positive with viral load greater than 1,000 copies/mL or cluster of differentiation 4 (CD4) count less than 350/mm\^3
13. Unwillingness to undergo randomization.
Exclusion Criteria
o There are some concurrent studies, even those designed to test an intervention, which may be compatible with the current study; this will be reviewed by the investigative leadership team on a case-by-case basis.
2. Previous participation in the PTBCARE+ program in another pregnancy, with randomization to the PTBCARE+ (active intervention) group.
3. Current, ongoing, illicit drug use ≥ 12 weeks gestation.
* Use of tobacco and/or marijuana products is not an exclusion.
* Receiving treatment for opioid use disorder with methadone, suboxone, or similar in an approved treatment program is not an exclusion.
4. History of radical trachelectomy
5. Planned voluntary termination of pregnancy.
6. Heavy vaginal bleeding or large subchorionic hemorrhage - defined as:
* Bleeding as primary reason for unplanned clinic evaluation or emergency room visit within 14 days of potential enrollment
* Subjective bleeding accompanied by ≥ 4 point drop in the hematocrit within 14 days of potential enrollment
* Subchorionic hemorrhage or abruption on formal ultrasound with a volume ≥ 64 cubic cm (4cm x 4cm x 4cm) within 14 days of potential enrollment
7. Major congenital anomaly such as major structural deficit of the heart, lungs, brain, or other major organ system
1. Mild renal abnormalities, clubfoot, isolated cleft lip/palate, etc. in the fetus are not a reason for exclusion.
2. Isolated 'soft markers' for aneuploidy (such as choroid plexus cysts, echogenic bowel, etc.) are not a reason for exclusion.
3. If a major congenital anomaly is diagnosed \*after\* enrollment, the patient will continue to participate in the study, however, the investigators will plan to analyze the study results with and without these individuals included.
8. Positive aneuploidy screening test (traditional biochemical assay, e.g., quad screen - risk of aneuploidy of 1:25 or higher or cell free deoxynucleic acid (DNA) test result that is screen positive for trisomy 13, trisomy 18, trisomy 21, or sex chromosome abnormality) in the absence of definitive fetal karyotype evaluation.
* Definitive fetal karyotype evaluation can only be obtained through direct testing of the tissue from the conceptus - by chorionic villus sampling or amniocentesis during pregnancy.
9. Cystic hygroma or abnormally thickened nuchal translucency ≥ 3 mm at any time in the current gestation, regardless of subsequent diagnostic testing results.
* Note that a cystic hygroma remains an exclusion criterion regardless of subsequent diagnostic testing results because fetuses with this history carry an elevated risk of major congenital heart disease.
* Fetal echocardiogram is most accurately performed at 22-24 weeks gestation, which is later than the enrollment gestational age window.
10. Polyhydramnios at or prior to enrollment.
o Polyhydramnios is defined as a maximum vertical pocket ≥ 8.0 cm, given that polyhydramnios \<22 weeks has a high likelihood of being associated with congenital anomalies/aneuploidy and/or preterm birth due to preterm prelabor rupture of membranes.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Minority Health and Health Disparities (NIMHD)
NIH
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tracy Manuck, MD
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of North Carolina School of Medicine - Chapel Hill
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Park S, Marcotte R, Staudenmayer J, Sirard J, VanKim N, Pekow P, Strath S, Freedson P, Chasan-Taber L. Validity of the Pregnancy Physical Activity Questionnaire Short Form (PPAQ-SF). Am J Epidemiol. 2024 Oct 2:kwae382. doi: 10.1093/aje/kwae382. Online ahead of print.
Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996 Mar 1;93(5):1043-65. No abstract available.
Hux VJ, Roberts JM. A potential role for allostatic load in preeclampsia. Matern Child Health J. 2015 Mar;19(3):591-7. doi: 10.1007/s10995-014-1543-7.
Heshmati S, Kibrislioglu Uysal N, Kim SH, Oravecz Z, Donaldson SI. Momentary PERMA: An Adapted Measurement Tool for Studying Well-Being in Daily Life. J Happiness Stud. 2023;24(8):2441-2472. doi: 10.1007/s10902-023-00684-w. Epub 2023 Sep 22.
Addison C, Jenkins B, White M. User Manual for Coping Strategies Inventory Short Form (CSI-SF)-The Jackson Heart Study. Int J Environ Res Public Health. 2024 Apr 4;21(4):443. doi: 10.3390/ijerph21040443.
Luszczynska A, Scholz U, Schwarzer R. The general self-efficacy scale: multicultural validation studies. J Psychol. 2005 Sep;139(5):439-57. doi: 10.3200/JRLP.139.5.439-457.
Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief resilience scale: assessing the ability to bounce back. Int J Behav Med. 2008;15(3):194-200. doi: 10.1080/10705500802222972.
Moser A, Stuck AE, Silliman RA, Ganz PA, Clough-Gorr KM. The eight-item modified Medical Outcomes Study Social Support Survey: psychometric evaluation showed excellent performance. J Clin Epidemiol. 2012 Oct;65(10):1107-16. doi: 10.1016/j.jclinepi.2012.04.007. Epub 2012 Jul 20.
Mustillo S, Krieger N, Gunderson EP, Sidney S, McCreath H, Kiefe CI. Self-reported experiences of racial discrimination and Black-White differences in preterm and low-birthweight deliveries: the CARDIA Study. Am J Public Health. 2004 Dec;94(12):2125-31. doi: 10.2105/ajph.94.12.2125.
Hall LA, Williams CA, Greenberg RS. Supports, stressors, and depressive symptoms in low-income mothers of young children. Am J Public Health. 1985 May;75(5):518-22. doi: 10.2105/ajph.75.5.518.
DeFranco EA, Hall ES, Muglia LJ. Racial disparity in previable birth. Am J Obstet Gynecol. 2016 Mar;214(3):394.e1-7. doi: 10.1016/j.ajog.2015.12.034. Epub 2015 Dec 22.
Hamilton BE, Martin JA, Osterman MJ, Curtin SC, Matthews TJ. Births: Final Data for 2014. Natl Vital Stat Rep. 2015 Dec;64(12):1-64.
Vianna P, Bauer ME, Dornfeld D, Chies JA. Distress conditions during pregnancy may lead to pre-eclampsia by increasing cortisol levels and altering lymphocyte sensitivity to glucocorticoids. Med Hypotheses. 2011 Aug;77(2):188-91. doi: 10.1016/j.mehy.2011.04.007. Epub 2011 May 6.
Wadhwa PD, Entringer S, Buss C, Lu MC. The contribution of maternal stress to preterm birth: issues and considerations. Clin Perinatol. 2011 Sep;38(3):351-84. doi: 10.1016/j.clp.2011.06.007.
Vohr B. Long-term outcomes of moderately preterm, late preterm, and early term infants. Clin Perinatol. 2013 Dec;40(4):739-51. doi: 10.1016/j.clp.2013.07.006. Epub 2013 Sep 20.
Bodeau-Livinec F, Marlow N, Ancel PY, Kurinczuk JJ, Costeloe K, Kaminski M. Impact of intensive care practices on short-term and long-term outcomes for extremely preterm infants: comparison between the British Isles and France. Pediatrics. 2008 Nov;122(5):e1014-21. doi: 10.1542/peds.2007-2976.
Manuck TA, Sheng X, Yoder BA, Varner MW. Correlation between initial neonatal and early childhood outcomes following preterm birth. Am J Obstet Gynecol. 2014 May;210(5):426.e1-9. doi: 10.1016/j.ajog.2014.01.046.
Manuck TA, Rice MM, Bailit JL, Grobman WA, Reddy UM, Wapner RJ, Thorp JM, Caritis SN, Prasad M, Tita AT, Saade GR, Sorokin Y, Rouse DJ, Blackwell SC, Tolosa JE; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Preterm neonatal morbidity and mortality by gestational age: a contemporary cohort. Am J Obstet Gynecol. 2016 Jul;215(1):103.e1-103.e14. doi: 10.1016/j.ajog.2016.01.004. Epub 2016 Jan 7.
Russell RB, Green NS, Steiner CA, Meikle S, Howse JL, Poschman K, Dias T, Potetz L, Davidoff MJ, Damus K, Petrini JR. Cost of hospitalization for preterm and low birth weight infants in the United States. Pediatrics. 2007 Jul;120(1):e1-9. doi: 10.1542/peds.2006-2386.
Related Links
Access external resources that provide additional context or updates about the study.
Contains study brochure, provided to potentially interested participants
Health-related social determinants of health including financial stress, as per the NC Department of Health and Human Services consensus
information regarding heart rate variability and health and regarding software for heart rate variability analysis
information regarding heartmath sensor and application for heart rate variability data capture and analysis
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-1779
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.